Description

BSE circular on securities moving into, within, and out of the Long Term Additional Surveillance Measure framework effective December 02, 2025.

Summary

BSE has issued a circular regarding the applicability of Long Term Additional Surveillance Measure (LT-ASM) framework effective December 02, 2025. One security - Caprolactam Chemicals Ltd (Scrip Code: 507486) - has been shortlisted for inclusion in the LT-ASM framework. No securities are being moved to higher or lower ASM stages, and no securities are exiting the framework.

Key Points

  • Caprolactam Chemicals Ltd (ISIN: INE470N01010) shortlisted in Long Term ASM Framework
  • Effective date: December 02, 2025
  • No securities moving to higher ASM stages
  • No securities moving to lower ASM stages
  • No securities moving out of LT-ASM framework
  • No securities shortlisted for direct Stage IV placement
  • Consolidated list includes multiple securities across ASM Stages I, II, and IV

Regulatory Changes

The Long Term Additional Surveillance Measure framework continues to be applied as per existing BSE guidelines. This circular represents a periodic update to the list of securities under surveillance rather than a change to the framework itself.

Compliance Requirements

  • Market participants should note the inclusion of Caprolactam Chemicals Ltd in LT-ASM framework
  • Trading in securities under LT-ASM is subject to additional surveillance measures including potential deposit requirements and trading restrictions
  • Investors and brokers must comply with applicable ASM stage requirements for affected securities

Important Dates

  • Effective Date: December 02, 2025 - New LT-ASM classifications become applicable

Impact Assessment

Market Impact: Limited impact as only one security is being newly included in the framework. The inclusion of Caprolactam Chemicals Ltd in LT-ASM may result in reduced liquidity and trading activity due to surveillance measures.

Operational Impact: Brokers and trading members need to update their systems to reflect the LT-ASM status for Caprolactam Chemicals Ltd. Additional margin and deposit requirements may apply for trading in this security.

Investor Impact: Investors holding or trading Caprolactam Chemicals Ltd should be aware of enhanced surveillance measures that may include higher margins, deposit requirements, or trading restrictions depending on the specific ASM stage applicable.

Impact Justification

Affects one security entering LT-ASM framework with potential trading restrictions, but no securities moving to higher stages or exiting the framework